Neutralizing activity < Neutralizing antibodies < Neutralizing antibody

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by Neutralizing antibodies

Number of relevant bibliographic references: 21.
[0-20] [0 - 20][0 - 21][20-20][20-40]

Ident.	Authors (with country if any)	Title
002C73 (2007)	C. V. Sapan ; H. M. Reisner [États-Unis] ; R. L. Lundblad [États-Unis]	Antibody therapy (IVIG): evaluation of the use of genomics and proteomics for the study of immunomodulation therapeutics
003569 (2001)	Anders Bolmstedt [Suède] ; Jorma Hinkula [Suède] ; Eric Rowcliffe [Suède] ; Marlene Biller [Suède] ; Britta Wahren [Suède] ; Sigvard Olofsson [Suède]	Enhanced immunogenicity of a human immunodeficiency virus type 1 env DNA vaccine by manipulating N-glycosylation signals
003661 (2000)	D. M Theisen [Luxembourg (pays)] ; F. B Bouche [Luxembourg (pays)] ; K. C El Kasmi [Luxembourg (pays)] ; I. Von Der Ahe [Luxembourg (pays)] ; W. Ammerlaan [Luxembourg (pays)] ; S. Demotz [Suisse] ; C. P Muller [Luxembourg (pays)]	Differential antigenicity of recombinant polyepitope-antigens based on loop- and helix-forming B and T cell epitopes
003748 (2000)	Jorge Luis Martinez-Torrecuadrada [Espagne] ; José R. Cast N [Espagne] ; Marian Castro [Espagne] ; José L. Carrascosa [Espagne] ; José F. Rodriguez [Espagne] ; J. Ignacio Casal [Espagne]	Different Architectures in the Assembly of Infectious Bursal Disease Virus Capsid Proteins Expressed in Insect Cells
003762 (2000)	Rongqi Wang [États-Unis] ; Golam Alam [États-Unis] ; Alex Zagariya [États-Unis] ; Claudia Gidea [États-Unis] ; Hugo Pinillos [États-Unis] ; Omosalewa Lalude [États-Unis] ; Gaurav Choudhary [États-Unis] ; Devlet Oezatalay [États-Unis] ; Bruce D. Uhal [États-Unis]	Apoptosis of lung epithelial cells in response to TNF‐α requires angiotensin II generation de novo
003848 (1999)	Andree Zibert [Allemagne] ; Wolfgang Kraas [Allemagne] ; R. Stefan Ross [Allemagne] ; Helga Meisel [Allemagne] ; Sabine Lechner [Allemagne] ; Günther Jung [Allemagne] ; Michael Roggendorf [Allemagne]	Immunodominant B-cell domains of hepatitis C virus envelope proteins E1 and E2 identified during early and late time points of infection
003965 (1999)	Jorge L. Mart Amp X0301 Nez-Torrecuadrada [Espagne] ; Jan P. M. Langeveld [Pays-Bas] ; Angel Venteo [Espagne] ; Antonio Sanz [Espagne] ; Kristian Dalsgaard [Danemark] ; William D. O. Hamilton [Royaume-Uni] ; Rob H. Meloen [Pays-Bas] ; J. Ignacio Casal [Espagne]	Antigenic Profile of African Horse Sickness Virus Serotype 4 VP5 and Identification of a Neutralizing Epitope Shared with Bluetongue Virus and Epizootic Hemorrhagic Disease Virus
003A62 (1998)	I. M Fernández [Pays-Bas] ; H. Golding [États-Unis] ; B. J Benaissa-Trouw [Pays-Bas] ; N. M De Vos [Pays-Bas] ; M. Harmsen [Pays-Bas] ; H. S. L. M Nottet [Pays-Bas] ; B. Golding [États-Unis] ; W. C Puijk [Pays-Bas] ; R. H Meloen [Pays-Bas] ; H. Snippe [Pays-Bas] ; C. A Kraaijeveld [Pays-Bas]	Induction of HIV-1 IIIb neutralizing antibodies in BALBc mice by a chimaeric peptide consisting of a T-helper cell epitope of Semliki Forest virus and a B-cell epitope of HIV
003B14 (1998)	Jonathan L. Heeney [Pays-Bas] ; Mariëlle E. Van Gils [Pays-Bas] ; Peter Van Der Meide [Pays-Bas] ; Carlo De Giuli Morghen [Italie] ; Cristina Ghioni [Italie] ; Margherita Gimelli [Italie] ; Antonio Raddelli [Italie] ; David Davis [Belgique] ; Lennart Akerblom [Suède] ; Bror Morein [Suède]	The role of type‐1 and type‐2 T‐helper immune responses in HIV‐1 vaccine protection
003B57 (1998)	Per Putkonen [Suède] ; Marlene Quesada-Rolander [Suède] ; Ann-Charlotte Leandersson [Suède] ; Stefan Schwartz [Suède] ; Rigmor Thorstensson [Suède] ; Kenji Okuda [Japon] ; Britta Wahren [Suède] ; Jorma Hinkula [Suède]	Immune Responses but No Protection against SHIV by Gene-Gun Delivery of HIV-1 DNA Followed by Recombinant Subunit Protein Boosts
003B80 (1998)	Ralf Wagner [Allemagne] ; Vera J. P. Teeuwsen [Pays-Bas] ; Ludwig Deml [Allemagne] ; Frank Notka [Allemagne] ; Anthonius G. M. Haaksma [Pays-Bas] ; Sunita S. Jhagjhoorsingh [Pays-Bas] ; Henk Niphuis [Pays-Bas] ; Hans Wolf [Allemagne] ; Jonathan L. Heeney [Pays-Bas]	Cytotoxic T Cells and Neutralizing Antibodies Induced in Rhesus Monkeys by Virus-like Particle HIV Vaccines in the Absence of Protection from SHIV Infection
003B89 (1998)	Sabine Lechner ; Kay Rispeter ; Helga Meisel [Allemagne] ; Wolfgang Kraas [Allemagne] ; Günther Jung [Allemagne] ; Michael Roggendorf ; Andree Zibert	Antibodies Directed to Envelope Proteins of Hepatitis C Virus Outside of Hypervariable Region 1
003C63 (1997)	Mercedes Garcia-Valcarcel [Royaume-Uni] ; Wendy J. Fowler [Royaume-Uni] ; David R. Harper [Royaume-Uni] ; Donald J. Jeffries [Royaume-Uni] ; Guy T. Layton [Royaume-Uni]	Induction of neutralizing antibody and T-cell responses to Varicella-zoster virus (VZV) using Ty-virus-like particles carrying fragments of glycoprotein E (gE)
003D45 (1997)	T. C. Harder [Pays-Bas] ; A. D. M. E. Osterhaus [Pays-Bas]	Molecular Characterization and Baculovirus Expression of the Glycoprotein B of a Seal Herpesvirus (Phocid Herpesvirus-1)
003F67 (1996)	D. Fenoglio [Italie] ; G. Li Pira [Italie] ; D. Saverino [Italie] ; A. Ferraris [Italie] ; F. Lancia [Italie] ; A. Megiovanni [Italie] ; L. Oppezzi [Italie] ; G. Piatti [Italie] ; F. Buffa [Italie] ; M. T. Valle [Italie] ; A. Kunkl [Italie] ; F. Manca [Italie]	Handling of retroviral antigens by human antigen-presenting cells
004121 (1995)	L. E. Brown [Australie] ; D. O. White [Australie] ; C. Agius [Australie] ; B. E. Kemp ; N. Yatzakis [Australie] ; P. Poumbourios ; D. A. Mcphee [Australie] ; D. C. Jackson [Australie]	Synthetic peptides representing sequences within gp41 of HIV as immunogens for murine T- and B-cell responses
004418 (1994)	Yechiel Becker [Israël]	Need for cellular and humoral immune responses in bovines to ensure protection from foot-and-mouth disease virus (FMDV)—A point of view
004571 (1993)	Kees Weijer [Pays-Bas] ; Anita Pfauth [Pays-Bas] ; Rob Van Herwijnen [Pays-Bas] ; Oswald Jarrett [Royaume-Uni] ; Rob H. Meloen [Pays-Bas] ; Chris Tomee [Pays-Bas] ; Albert D. M. E. Osterhaus [Pays-Bas]	Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene
004806 (1992)		Oral presentations
004824 (1992)	A. Ebersold [France] ; V. Boyer [France] ; P. J. Klasse [Suède] ; M. Holnigue [France] ; C. Fraisier [France] ; J. M. Cocchi [France] ; R. Pipkorn [Allemagne] ; J. Blomberg [Suède] ; C. Desgranges [France]	Human and murine monoclonal antibodies directed against a conserved sequence from gp41 (aa583–599) of human immunodeficiency virus type 1
004C28 (1988)	Marvin S. Reitz Jr. [États-Unis] ; Carolyn Wilson [États-Unis] ; Christine Naugle [États-Unis] ; Robert C. Gallo [États-Unis] ; Marjorie Robert-Guroff [États-Unis]	Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Neutralizing antibodies" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i  \
                -Sk "Neutralizing antibodies" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Neutralizing antibodies
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021